Stacy Loeb, MD, MSc, discusses a study evaluating levels of at microplastics and nanoplastics in prostate cancer tissue. Loeb explained that her interest in this work was sparked by a study published ...

QUILT 2.005 is an open-label, multicenter trial randomizing BCG-naïve high-grade NMIBC patients to Anktiva+BCG versus BCG monotherapy across CIS (cohort A) and papillary-only (cohort B) cohorts.

FDA approved VYBRIQUE, an orally dissolving sildenafil film for erectile dysfunction in men ≥18 years, supported by a 12-week phase 3 trial showing significant benefit over placebo. Discreet, ...

Healthcare professionals discuss the importance of addressing quality of life and exercise for patients starting androgen deprivation therapy. When initiating ADT, how do you frame discussions around ...

Christopher P. Filson, MD, MS, highlights a study evaluating the real-world utility of incorporating the CxBladder Triage test to the diagnostic workflow for microhematuria. In this video, Christopher ...

Singh concludes that increasing physician awareness and comfort with low-dose imaging is key to reducing unnecessary radiation while maintaining diagnostic accuracy and patient safety. In this video, ...

Boxed warnings were removed from Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva, spanning progestogen-only, systemic estrogen-only, topical vaginal estrogen, and combined systemic ...

A negative PSMA-PET/CT at BCR identified a favorable-risk group with 2- and 5-year PFS of 78.3% and 62.4%, respectively, despite no visible lesions. Whole-pelvis radiotherapy improved PFS in locally ...